Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $684224.0.

  • Cumberland Pharmaceuticals' Change in Accured Expenses fell 4564.56% to $684224.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year increase of 5826.9%. This contributed to the annual value of -$991359.0 for FY2024, which is 2945.89% up from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Change in Accured Expenses is $684224.0, which was down 4564.56% from -$1.4 million recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Change in Accured Expenses high stood at $5.8 million for Q4 2022, and its period low was -$3.3 million during Q4 2023.
  • Its 5-year average for Change in Accured Expenses is $528792.7, with a median of $134727.0 in 2021.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 295792.38% in 2022, then tumbled by 18582.1% in 2024.
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Change in Accured Expenses stood at $2.1 million in 2021, then surged by 172.09% to $5.8 million in 2022, then plummeted by 157.46% to -$3.3 million in 2023, then surged by 90.2% to -$324294.0 in 2024, then skyrocketed by 310.99% to $684224.0 in 2025.
  • Its Change in Accured Expenses stands at $684224.0 for Q3 2025, versus -$1.4 million for Q2 2025 and -$600043.0 for Q1 2025.